ESSIC uses the name bladder pain syndrome (BPS) instead of interstitial cystitis (IC) and/or painful bladder syndrome (PBS): click here for more details.
Diagnosis of interstitial cystitis/ painful bladder syndrome in patients with overactive bladder symptoms.
Macdiarmid SA, Sand PK. Rev Urol 2007;9:9-16
• overactive bladder (OAB) and interstitial cystitis (IC) have similar symptoms, including urinary urgency/frequency and nocturia, making them difficult to differentiate on the basis of clinical presentation alone
• the authors propose a diagnostic framework that may be useful for differentiating IC from OAB and for facilitating appropriate treatment
Gauruder-Burmester A, Wildt B, Tunn R. Zentralbl Gynakol 2006;128:336-40
• in this prospective randomized study it was tested whether instillation of sodium chondroitin sulphate for treatment of interstitial cystitis was also effective in treating overactive bladder
• 82 patients with chronic overactive bladder were randomized to one of two study groups A or B; group A was treated with an anticholinergic agent (tolterodine), group B with sodium chondroitin sulphate (Uropol S); patients were treated for 12 months
• the diagnosis was established on the basis of a gynecologic examination and history, urodynamic testing, introital ultrasound, and cystoscopy
• an improvement of symptoms was reported by 15/35 (43 %) of the patients in group A as compared with 23/32 (72 %) of the patients in group B; the subjective outcome was corroborated by means of urodynamic testing, number of pads used, voiding frequency, and nycturia (voiding diary); quality of life increased significantly in both groups in the course of treatment but there was no significant difference between both groups
• the authors conclude that restoring the glycosaminoglycan layer also improves or cures the symptoms in patients with overactive bladder